ArticleFrontiers in neurology2025
Urodynamic evaluation of neurogenic lower urinary tract dysfunction in children with Guillain-Barre syndrome within 6 months.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Indications, findings, and clinical impact of invasive pediatric urodynamic studies in Iraqi children.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate urodynamic characteristics, identify high-risk and unfavorable urodynamic findings in children with neurogenic lower urinary tract dysfunction (NLUTD) secondary to Guillain-Barre syndrome (GBS) within 6 months since the onset of illness. Methods: This study conducted a retrospective observational analysis of 16 children diagnosed with GBS complicated by NLUTD. Clinical data collected included demographic information, lower urinary tract symptoms, uroflowmetry results, post-void residual urine (PVRU), and urodynamic parameters. Follow-up assessments focused on high-risk urodynamic features-such as high detrusor pressure during the filling phase and low bladder compliance-as well as unfavorable findings, including detrusor overactivity, detrusor underactivity, or an acontractile bladder. Results: The majority of patients presented with clinical symptoms of urinary retention. Characterized by a decreased Qmax on uroflowmetry and elevated PVRU. Urodynamic study (UDS) revealed two predominant findings: reduced bladder sensation during the filling phase and detrusor underactivity during the voiding phase. At the 8-week follow-up, low bladder compliance and detrusor overactivity were observed in only 2 of the 16 patients (12.5%). During the filling phase, none of the patients exhibited high detrusor pressure (>40 cmH₂O), while all cases demonstrated underactive bladder function during the voiding phase. By the 24-week follow-up, 12 patients (12/16, 75.0%) had achieved normal bladder compliance, with only one case persisting with low bladder compliance and detrusor overactivity. Additionally, 10 patients (10/16, 62.5%) who had presented with an underactive bladder during the voiding phase showed recovery by the 24-week assessment. Conclusion: The prognosis of autonomic dysfunction involving the urinary system in pediatric GBS was generally favorable, with most cases of GBS-associated NLUTS showing substantial reversibility, as confirmed by the normalization of urodynamic parameters over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.